Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1993 Dec;77(12):799–804. doi: 10.1136/bjo.77.12.799

Immunohistochemical analysis of lattice corneal dystrophies types I and II.

T Kivelä 1, A Tarkkanen 1, I McLean 1, J Ghiso 1, B Frangione 1, M Haltia 1
PMCID: PMC504660  PMID: 8110676

Abstract

Corneal buttons from four patients with lattice corneal dystrophy (LD) type I, thought to be an isolated corneal amyloidosis, and from six patients with LD type II, part of systemic familial amyloidosis, Finnish type (FAF; Meretoja's syndrome), were studied by immunohistochemistry to determine the differential distribution in the amyloid deposits of amyloid P component (AP), mutated gelsolin specific for FAF, and native gelsolin. In both types of LD, antibodies to AP labelled lattice lines and a discontinuous layer of amyloid deposits under Bowman's layer. In LD type II, particularly, they also reacted with streak-like amyloid deposits between corneal almellae, especially in the limbal region. While the anti-FAF antiserum strongly labelled all amyloid deposits in LD type II, it failed to react unequivocally with them in LD type I. Both in LD type I and in two control specimens representing granular dystrophy, the monoclonal antibody (MAb) GS-2C4 to gelsolin faintly labelled some deposits, while in LD type II it reacted non-homogeneously with most amyloid deposits. In all specimens, MAb GS-2C4 labelled corneal epithelial cells and occasional stromal keratocytes and endothelial cells. The results suggest that Meretoja's syndrome, a systemic disease, can be diagnosed even retrospectively from corneal buttons subjected to histopathological study.

Full text

PDF
799

Images in this article

801Image
on p.801
802Image
on p.802
803Image
on p.803

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boysen G., Galassi G., Kamieniecka Z., Schlaeger J., Trojaborg W. Familial amyloidosis with cranial neuropathy and corneal lattice dystrophy. J Neurol Neurosurg Psychiatry. 1979 Nov;42(11):1020–1030. doi: 10.1136/jnnp.42.11.1020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chaponnier C., Janmey P. A., Yin H. L. The actin filament-severing domain of plasma gelsolin. J Cell Biol. 1986 Oct;103(4):1473–1481. doi: 10.1083/jcb.103.4.1473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Darras B. T., Adelman L. S., Mora J. S., Bodziner R. A., Munsat T. L. Familial amyloidosis with cranial neuropathy and corneal lattice dystrophy. Neurology. 1986 Mar;36(3):432–435. doi: 10.1212/wnl.36.3.432. [DOI] [PubMed] [Google Scholar]
  4. Ghiso J., Haltia M., Prelli F., Novello J., Frangione B. Gelsolin variant (Asn-187) in familial amyloidosis, Finnish type. Biochem J. 1990 Dec 15;272(3):827–830. doi: 10.1042/bj2720827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gorevic P. D., Munoz P. C., Gorgone G., Purcell J. J., Jr, Rodrigues M., Ghiso J., Levy E., Haltia M., Frangione B. Amyloidosis due to a mutation of the gelsolin gene in an American family with lattice corneal dystrophy type II. N Engl J Med. 1991 Dec 19;325(25):1780–1785. doi: 10.1056/NEJM199112193252505. [DOI] [PubMed] [Google Scholar]
  6. Gorevic P. D., Rodrigues M. M., Krachmer J. H., Green C., Fujihara S., Glenner G. G. Lack of evidence for protein AA reactivity in amyloid deposits of lattice corneal dystrophy and amyloid corneal degeneration. Am J Ophthalmol. 1984 Aug 15;98(2):216–224. doi: 10.1016/0002-9394(87)90357-6. [DOI] [PubMed] [Google Scholar]
  7. Haltia M., Ghiso J., Prelli F., Gallo G., Kiuru S., Somer H., Palo J., Frangione B. Amyloid in familial amyloidosis, Finnish type, is antigenically and structurally related to gelsolin. Am J Pathol. 1990 Jun;136(6):1223–1228. [PMC free article] [PubMed] [Google Scholar]
  8. Haltia M., Levy E., Meretoja J., Fernandez-Madrid I., Koivunen O., Frangione B. Gelsolin gene mutation--at codon 187--in familial amyloidosis, Finnish: DNA-diagnostic assay. Am J Med Genet. 1992 Feb 1;42(3):357–359. doi: 10.1002/ajmg.1320420321. [DOI] [PubMed] [Google Scholar]
  9. Haltia M., Prelli F., Ghiso J., Kiuru S., Somer H., Palo J., Frangione B. Amyloid protein in familial amyloidosis (Finnish type) is homologous to gelsolin, an actin-binding protein. Biochem Biophys Res Commun. 1990 Mar 30;167(3):927–932. doi: 10.1016/0006-291x(90)90612-q. [DOI] [PubMed] [Google Scholar]
  10. Hida T., Proia A. D., Kigasawa K., Sanfilippo F. P., Burchette J. L., Jr, Akiya S., Klintworth G. K. Histopathologic and immunochemical features of lattice corneal dystrophy type III. Am J Ophthalmol. 1987 Sep 15;104(3):249–254. doi: 10.1016/0002-9394(87)90412-0. [DOI] [PubMed] [Google Scholar]
  11. Hida T., Tsubota K., Kigasawa K., Murata H., Ogata T., Akiya S. Clinical features of a newly recognized type of lattice corneal dystrophy. Am J Ophthalmol. 1987 Sep 15;104(3):241–248. doi: 10.1016/0002-9394(87)90411-9. [DOI] [PubMed] [Google Scholar]
  12. Hiltunen T., Kiuru S., Hongell V., Heliö T., Palo J., Peltonen L. Finnish type of familial amyloidosis: cosegregation of Asp187----Asn mutation of gelsolin with the disease in three large families. Am J Hum Genet. 1991 Sep;49(3):522–528. [PMC free article] [PubMed] [Google Scholar]
  13. Kivelä T. Antigenic profile of the human lacrimal gland. J Histochem Cytochem. 1992 May;40(5):629–642. doi: 10.1177/40.5.1374091. [DOI] [PubMed] [Google Scholar]
  14. Klintworth G. K., Ferry A. P., Sugar A., Reed J. Recurrence of lattice corneal dystrophy type 1 in the corneal grafts of two siblings. Am J Ophthalmol. 1982 Oct;94(4):540–546. doi: 10.1016/0002-9394(82)90251-3. [DOI] [PubMed] [Google Scholar]
  15. Klintworth G. K. Lattice corneal dystrophy. An inherited variety of amyloidosis restricted to the cornea. Am J Pathol. 1967 Mar;50(3):371–399. [PMC free article] [PubMed] [Google Scholar]
  16. Kwiatkowski D. J., Mehl R., Yin H. L. Genomic organization and biosynthesis of secreted and cytoplasmic forms of gelsolin. J Cell Biol. 1988 Feb;106(2):375–384. doi: 10.1083/jcb.106.2.375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Levy E., Haltia M., Fernandez-Madrid I., Koivunen O., Ghiso J., Prelli F., Frangione B. Mutation in gelsolin gene in Finnish hereditary amyloidosis. J Exp Med. 1990 Dec 1;172(6):1865–1867. doi: 10.1084/jem.172.6.1865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Loeffler K. U., Edward D. P., Tso M. O. An immunohistochemical study of gelsolin immunoreactivity in corneal amyloidosis. Am J Ophthalmol. 1992 May 15;113(5):546–554. doi: 10.1016/s0002-9394(14)74728-2. [DOI] [PubMed] [Google Scholar]
  19. Loveless R. W., Floyd-O'Sullivan G., Raynes J. G., Yuen C. T., Feizi T. Human serum amyloid P is a multispecific adhesive protein whose ligands include 6-phosphorylated mannose and the 3-sulphated saccharides galactose, N-acetylgalactosamine and glucuronic acid. EMBO J. 1992 Mar;11(3):813–819. doi: 10.1002/j.1460-2075.1992.tb05118.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Maury C. P., Alli K., Baumann M. Finnish hereditary amyloidosis. Amino acid sequence homology between the amyloid fibril protein and human plasma gelsoline. FEBS Lett. 1990 Jan 15;260(1):85–87. doi: 10.1016/0014-5793(90)80072-q. [DOI] [PubMed] [Google Scholar]
  21. Maury C. P., Baumann M. Isolation and characterization of cardiac amyloid in familial amyloid polyneuropathy type IV (Finnish): relation of the amyloid protein to variant gelsolin. Biochim Biophys Acta. 1990 Nov 14;1096(1):84–86. doi: 10.1016/0925-4439(90)90016-i. [DOI] [PubMed] [Google Scholar]
  22. Maury C. P. Gelsolin-related amyloidosis. Identification of the amyloid protein in Finnish hereditary amyloidosis as a fragment of variant gelsolin. J Clin Invest. 1991 Apr;87(4):1195–1199. doi: 10.1172/JCI115118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Maury C. P., Kere J., Tolvanen R., de la Chapelle A. Finnish hereditary amyloidosis is caused by a single nucleotide substitution in the gelsolin gene. FEBS Lett. 1990 Dec 10;276(1-2):75–77. doi: 10.1016/0014-5793(90)80510-p. [DOI] [PubMed] [Google Scholar]
  24. Maury C. P., Kere J., Tolvanen R., de la Chapelle A. Homozygosity for the Asn187 gelsolin mutation in Finnish-type familial amyloidosis is associated with severe renal disease. Genomics. 1992 Jul;13(3):902–903. doi: 10.1016/0888-7543(92)90183-s. [DOI] [PubMed] [Google Scholar]
  25. Maury C. P., Nurmiaho-Lassila E. L. Creation of amyloid fibrils from mutant Asn187 gelsolin peptides. Biochem Biophys Res Commun. 1992 Feb 28;183(1):227–231. doi: 10.1016/0006-291x(92)91632-z. [DOI] [PubMed] [Google Scholar]
  26. Mehta R. F. Unilateral lattice dystrophy of the cornea. Br J Ophthalmol. 1980 Jan;64(1):53–55. doi: 10.1136/bjo.64.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Meretoja J. Comparative histopathological and clinical findings in eyes with lattice corneal dystrophy of two different types. Ophthalmologica. 1972;165(1):15–37. doi: 10.1159/000308469. [DOI] [PubMed] [Google Scholar]
  28. Meretoja J. Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. A previously unrecognized heritable syndrome. Ann Clin Res. 1969 Dec;1(4):314–324. [PubMed] [Google Scholar]
  29. Meretoja J. Genetic aspects of familial amyloidosis with corneal lattice dystrophy and cranial neuropathy. Clin Genet. 1973;4(3):173–185. doi: 10.1111/j.1399-0004.1973.tb01140.x. [DOI] [PubMed] [Google Scholar]
  30. Meretoja J., Teppo L. Histopathological findings of familial amyloidosis with cranial neuropathy as principal manifestation. Report on three cases. Acta Pathol Microbiol Scand A. 1971;79(5):432–440. doi: 10.1111/j.1699-0463.1971.tb01841.x. [DOI] [PubMed] [Google Scholar]
  31. Mondino B. J., Raj C. V., Skinner M., Cohen A. S., Brown S. I. Protein AA and lattice corneal dystrophy. Am J Ophthalmol. 1980 Mar;89(3):377–380. doi: 10.1016/0002-9394(80)90007-0. [DOI] [PubMed] [Google Scholar]
  32. Paunio T., Kiuru S., Hongell V., Mustonen E., Syvänen A. C., Bengström M., Palo J., Peltonen L. Solid-phase minisequencing test reveals Asp187----Asn (G654----A) mutation of gelsolin in all affected individuals with Finnish type of familial amyloidosis. Genomics. 1992 May;13(1):237–239. doi: 10.1016/0888-7543(92)90235-k. [DOI] [PubMed] [Google Scholar]
  33. Purcell J. J., Jr, Rodrigues M., Chishti M. I., Riner R. N., Dooley J. M. Lattice corneal dystrophy associated with familial systemic amyloidosis (Meretoja's syndrome). Ophthalmology. 1983 Dec;90(12):1512–1517. doi: 10.1016/s0161-6420(83)34369-4. [DOI] [PubMed] [Google Scholar]
  34. Rintala A. E., Alanko A., Mäkinen J., Nordström R., Salo H. Primary hereditary systemic amyloidosis (Meretoja's syndrome): clinical features and treatment by plastic surgery. Scand J Plast Reconstr Surg Hand Surg. 1988;22(2):141–145. doi: 10.3109/02844318809072386. [DOI] [PubMed] [Google Scholar]
  35. Rodrigues M. M., Robey P. G. C-reactive protein in human lattice corneal dystrophy. Curr Eye Res. 1982;2(10):721–724. doi: 10.3109/02713688209020002. [DOI] [PubMed] [Google Scholar]
  36. Sack G. H., Jr, Dumars K. W., Gummerson K. S., Law A., McKusick V. A. Three forms of dominant amyloid neuropathy. Johns Hopkins Med J. 1981 Dec;149(6):239–247. [PubMed] [Google Scholar]
  37. Sipe J. D. Amyloidosis. Annu Rev Biochem. 1992;61:947–975. doi: 10.1146/annurev.bi.61.070192.004503. [DOI] [PubMed] [Google Scholar]
  38. Starck T., Kenyon K. R., Hanninen L. A., Beyer-Machule C., Fabian R., Gorn R. A., McMullan F. D., Baum J., McAdam K. P. Clinical and histopathologic studies of two families with lattice corneal dystrophy and familial systemic amyloidosis (Meretoja syndrome). Ophthalmology. 1991 Aug;98(8):1197–1206. doi: 10.1016/s0161-6420(91)32153-5. [DOI] [PubMed] [Google Scholar]
  39. Sturrock G. D. Lattice corneal dystrophy: a source of confusion. Br J Ophthalmol. 1983 Sep;67(9):629–634. doi: 10.1136/bjo.67.9.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Waring G. O., 3rd, Rodrigues M. M., Laibson P. R. Corneal dystrophies. I. Dystrophies of the epithelium, Bowman's layer and stroma. Surv Ophthalmol. 1978 Sep-Oct;23(2):71–122. doi: 10.1016/0039-6257(78)90090-5. [DOI] [PubMed] [Google Scholar]
  41. Wheeler G. E., Eiferman R. A. Immunohistochemical identification of the AA protein in lattice dystrophy. Exp Eye Res. 1983 Feb;36(2):181–186. doi: 10.1016/0014-4835(83)90004-0. [DOI] [PubMed] [Google Scholar]
  42. Wiens A., Marles S., Safneck J., Kwiatkowski D. J., Maury C. P., Zelinski T., Philipps S., Ekins M. B., Greenberg C. R. Exclusion of the gelsolin gene on 9q32-34 as the cause of familial lattice corneal dystrophy type I. Am J Hum Genet. 1992 Jul;51(1):156–160. [PMC free article] [PubMed] [Google Scholar]
  43. Winkelman J. E., Delleman J. W., Ansink B. J. Ein hereditäres Syndrom, bestehend aus peripherer Polyneuopatie, Hauveränderungen und gittriger Dystrophie der Hornhaut. Klin Monbl Augenheilkd. 1971 Nov;159(5):618–623. [PubMed] [Google Scholar]
  44. de la Chapelle A., Kere J., Sack G. H., Jr, Tolvanen R., Maury C. P. Familial amyloidosis, Finnish type: G654----a mutation of the gelsolin gene in Finnish families and an unrelated American family. Genomics. 1992 Jul;13(3):898–901. doi: 10.1016/0888-7543(92)90182-r. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES